OpenVSafe by OpenVAERS
Search V-safe

JVV-88885-40468

2 vaccinations 4 coded responses 15 check-ins 4 free-text entries 0 call cases
Sex
Female
Age at first dose
31-35
ZIP prefix
462 / IN
Registered
2021-12-23
Relationship
Self
Race
White
Ethnicity
Not Hispanic or Latino

Timeline

  1. 2021-06-06
    Dose 1 — Janssen/Johnson & Johnson
  2. 2021-12-23
    Registered in v-safe
  3. 2021-12-23
    Dose 2 — Pfizer-BioNTech
  4. 2021-12-23
    Health check-in — day 0, dose 2
    Feeling: Good · Site: Pain · None
    Adult check-in
  5. 2021-12-24
    Health check-in — days 1–6 daily, dose 2
    Feeling: Fair · Site: Pain · Fatigue or tiredness, Nausea
    Adult check-in
  6. 2021-12-25
    Health check-in — days 1–6 daily, dose 2
    Feeling: Fair · Site: Pain · Headache, Fatigue or tiredness
    Adult check-in
  7. 2021-12-26
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · Site: Pain · None
    Adult check-in
  8. 2021-12-27
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · None
    Adult check-in
  9. 2021-12-28
    Survey response — days 1–6 daily, dose 2
    MedDRA: Oropharyngeal pain — Feeling: Fair
    Free text: Sore throat
    MedDRA releases: 2024-11 · check-in free text available
  10. 2021-12-29
    Survey response — days 1–6 daily, dose 2
    MedDRA: Ageusia, Anosmia, Cough, Oropharyngeal pain — Feeling: Poor · Be unable to work or attend school
    Free text: Cough, sore throat, loss of taste and smell
    MedDRA releases: 2024-11 · check-in free text available
  11. 2021-12-30
    Survey response — day 7, dose 2
    MedDRA: Cough, Respiratory tract congestion, SARS-CoV-2 test positive, Sneezing — Feeling: Poor · Headache, Fatigue or tiredness · Be unable to work or attend school, Be unable to do your normal daily activities
    Free text: Cough, congestion, sneezing, tested positive for covid
    MedDRA releases: 2024-11 · check-in free text available
  12. 2022-01-06
    Health check-in — day 14, dose 2
    Feeling: Fair
    Adult check-in
  13. 2022-01-13
    Health check-in — day 21, dose 2
    Feeling: Good
    Adult check-in
  14. 2022-01-20
    Health check-in — day 28, dose 2
    Feeling: Good
    Adult check-in
  15. 2022-01-27
    Health check-in — day 35, dose 2
    Feeling: Good
    Adult check-in
  16. 2022-02-03
    Health check-in — day 42, dose 2
    Feeling: Good
    Adult check-in
  17. 2022-03-24
    Health check-in — 3 months, dose 2
    Feeling: Good
    Adult check-in
  18. 2022-12-23
    Survey response — 12 months, dose 2
    MedDRA: Hyperthyroidism, Tinnitus — Feeling: Good
    Free text: Hyperthyroidism, ringing ears
    MedDRA releases: 2024-11 · check-in free text available

Vaccinations

DoseDateManufacturerCo-administered
12021-06-06Janssen/Johnson & Johnson No
22021-12-23Pfizer-BioNTech No

Free text

Release 10 — days 1–6 daily, dose 2

2021-12-28

Systemic reaction (other): Sore throat

2021-12-29

Systemic reaction (other): Cough, sore throat, loss of taste and smell

Release 10 — day 7, dose 2

2021-12-30

Systemic reaction (other): Cough, congestion, sneezing, tested positive for covid

Release 12 — 12 months, dose 2

2022-12-23

Symptoms: Hyperthyroidism, ringing ears

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
SDHyperthyroidism · · ✓
SDTinnitus · · ✓
SROAgeusia · · ✓
SROAnosmia · · ✓
SROCough · · ✓
SROOropharyngeal pain · · ✓
SRORespiratory tract congestion · · ✓
SROSARS-CoV-2 test positive · · ✓
SROSneezing · · ✓

✓ active code · ○ coded but marked inactive · blank = not in that release